IRIS Accounts Production v25.4.0.155 15772174 Board of Directors 11.6.24 30.6.25 30.6.25 0 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15772174 2024-06-10 15772174 2025-06-30 15772174 2024-06-11 2025-06-30 15772174 2024-06-10 15772174 ns15:EnglandWales 2024-06-11 2025-06-30 15772174 ns14:PoundSterling 2024-06-11 2025-06-30 15772174 ns10:Director1 2024-06-11 2025-06-30 15772174 ns10:PrivateLimitedCompanyLtd 2024-06-11 2025-06-30 15772174 ns10:SmallEntities 2024-06-11 2025-06-30 15772174 ns10:AuditExempt-NoAccountantsReport 2024-06-11 2025-06-30 15772174 ns10:SmallCompaniesRegimeForDirectorsReport 2024-06-11 2025-06-30 15772174 ns10:SmallCompaniesRegimeForAccounts 2024-06-11 2025-06-30 15772174 ns10:FullAccounts 2024-06-11 2025-06-30 15772174 ns10:Director2 2024-06-11 2025-06-30 15772174 ns10:CompanySecretary1 2024-06-11 2025-06-30 15772174 ns10:RegisteredOffice 2024-06-11 2025-06-30 15772174 ns5:CurrentFinancialInstruments 2025-06-30 15772174 ns5:ShareCapital 2025-06-30 15772174 ns5:RetainedEarningsAccumulatedLosses 2025-06-30

REGISTERED NUMBER: 15772174 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 11 JUNE 2024 TO 30 JUNE 2025

FOR

LS HEALTH UK PTY LTD

| LS HEALTH UK PTY LTD (REGISTERED NUMBER: 15772174) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE PERIOD 11 JUNE 2024 TO 30 JUNE 2025

Page |

| Company information | 1 |

| Balance sheet | 2 |

| Notes to the financial statements | 3 |

| LS HEALTH UK PTY LTD |

COMPANY INFORMATION

FOR THE PERIOD 11 JUNE 2024 TO 30 JUNE 2025

| Directors: | Ms L G Canny

| Ms S M Panton

| Secretary: | Vistra Cosec Limited

| Registered office: | Suite 1, 7th Floor

| 50 Broadway

| London

| SW1H 0DB

| Registered number: | 15772174 (England and Wales)

| LS HEALTH UK PTY LTD (REGISTERED NUMBER: 15772174) |

BALANCE SHEET

30 JUNE 2025

| Notes | £

| CURRENT ASSETS

| Debtors | 4 | 3,357 |  |

| Cash at bank | 466 |  |

3,823 |  |

| CREDITORS

| Amounts falling due within one year | 5 | (5,744 | ) |

| NET CURRENT LIABILITIES | (1,921 | ) |

| TOTAL ASSETS LESS CURRENT LIABILITIES | (1,921 | ) |

| CAPITAL AND RESERVES

| Called up share capital | 120 |  |

| Retained earnings | (2,041 | ) |

| SHAREHOLDERS' FUNDS | (1,921 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 May 2026 and were signed on its behalf by:

Ms L G Canny - Director

| LS HEALTH UK PTY LTD (REGISTERED NUMBER: 15772174) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD 11 JUNE 2024 TO 30 JUNE 2025

1. | STATUTORY INFORMATION

| LS Health UK Pty Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The Company’s functional and presentational currency is pounds sterling (GBP) and the financial statements have been rounded to the nearest pound (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS102 to all of its financial instruments.

| Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Classification of financial liabilities

| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into.

| Basic financial liabilities

| Basic financial liabilities, including creditors, and loans from fellow group companies are initially recognised at transaction price.

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are initially recognised at transaction price.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Going concern

| The financial statements are prepared using going concern despite the net liability position at the balance sheet date. The company is reliant on its parent company providing the necessary funding for it to meet its obligations as they fall due. The directors have received assurances that all necessary funding will be made available for a period of at least 12 months from the date of signing of these financial statements.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was NIL.

4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| £

| Amounts owed by group undertakings | 3,357 |  |

| LS HEALTH UK PTY LTD (REGISTERED NUMBER: 15772174) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE PERIOD 11 JUNE 2024 TO 30 JUNE 2025

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| £

| Trade creditors | 764 |  |

| Other creditors | 4,980 |  |

5,744 |  |

6. | ULTIMATE CONTROLLING PARTY

| The company's ultimate parent undertaking and controlling party is Longetivity Life Sciences Pty Ltd (formerly LS Health Pty Ltd) a company incorporated in Australia.